Kim K H, Kim H J, Kang J S, Mar W
College of Pharmany, Kangwon National University, Chuncheon, South Korea.
J Pharm Biomed Anal. 2000 Mar;22(2):377-84. doi: 10.1016/s0731-7085(99)00279-4.
Achiral chiral column switching HPLC assay was developed to allow the separation and quantitation of the enantiomers of metoprolol in human urine by means of fluorescence detection. Urine samples were prepared by liquid liquid extraction, followed by HPLC. The racemic metoprolol and internal standard were separated from the interfering components in urine and quantified on the silica column, and the enantiomers were determined on a Chiralcel OD chiral stationary phase. The two columns were connected by a switching valve equipped with a silica trap column. Detection limit was 25 ng/ml for each enantiomer. The intra-day variation ranged between 0.38 and 4.94% in relation to the measured concentration and the inter-day variation was 0.15-3.13%. It has been applied to the determination of (R)-(+)-metoprolol and (S)-(-)-metoprolol in urine from healthy volunteers dosed with racemic metoprolol tartrate.
开发了一种非手性-手性柱切换高效液相色谱法,通过荧光检测对人尿中美托洛尔对映体进行分离和定量。尿液样品通过液液萃取制备,然后进行高效液相色谱分析。外消旋美托洛尔和内标物与尿液中的干扰成分分离,并在硅胶柱上进行定量,对映体则在Chiralcel OD手性固定相上进行测定。两根柱子通过配备硅胶捕集柱的切换阀连接。每种对映体的检测限为25 ng/ml。日内变异相对于测量浓度在0.38%至4.94%之间,日间变异为0.15% - 3.13%。该方法已应用于给健康志愿者服用外消旋酒石酸美托洛尔后尿液中(R)-(+)-美托洛尔和(S)-(-)-美托洛尔的测定。